Company / FCF Margin
Immunocore Holdings plc FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-3.8%
FY2025
5-year range
-29.5% / 6.7%
FY2022-FY2025
Trend
-155.9%
vs FY2024
Sector context
#65 of 134
Health Care
What the data says
At -3.8%, Immunocore Holdings plc's fcf margin ranks #65 of 134 in the Health Care sector. Declined from -1.0% to -3.8% over the past 2 years.
Based on SEC 10-K filings.
-3.8% in FY2025 with a 3-year CAGR of +25.7%.
Declined from -1.0% to -3.8% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +25.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#65 of 134 in Health CareTop 49% of 134This company -3.8% Sector average -637.8%
▼
+99.4% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 155.9% year-over-year.
- Currently 634.0pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.8% | -155.9% |
| FY2024 | 6.7% | +773.0% |
| FY2023 | -1.0% | +96.6% |
| FY2022 | -29.5% | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026